KDR and neoplasm: The kinase inhibitor, Ki8751, selectively inhibited VEGFR2, and its introduction into tumor-CM decreased CAII mRNA expression in hNECs (Fig. 5c) and subsequently canceled the VEGFA-induced CAII protein expression (Fig. 5d).